Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream while Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream for its safety in breastfeeding.

What is the use of Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream ?

Sunscreen

Is using Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream high risk while breastfeeding
Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream consists two active ingredients Titanium dioxide and Octinoxate and as per our analysis of both we have determined the Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream in breastfeeding.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (5001000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.


I already used Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream and meanwhile I breastfed my baby should I be concerned?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream usage and time interval of breastfeeding.


My health care provider has asked me to use Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream, what to do?

If your doctor knows that you are breastfeeding mother and still prescribes Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream then there must be good reason for that as Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Rejuvenating Bb | Titanium Dioxde, Octinoxate Cream in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week